Sri Lanka has approved the emergency use of the Chinese Sinovac vaccine against COVID-19.
It is the second Chinese COVID-19 vaccine approved by Sri Lanka's National Medicines Regulatory Authority (NMRA), News First reported.
The country has already been administrating China's Sinopharm vaccine. China on Thursday announced that it will donate another 1.6 million doses of the Sinopharm COVID-19 vaccine to Sri Lanka.
Besides this, Covishield, Sputnik and Pfizer vaccines are also being administrated in the country.
Sinovac CoronaVac has been developed by Sinovac/China National Pharmaceutical Group.
In June, the WHO Strategic Advisory Group of Experts (SAGE) on Immunization has issued Interim recommendations for the use of the inactivated COVID-19 vaccine.
According to the data published by the Epidemiology Unit of the Ministry of Health showed that, as of Thursday, more than 51 lakh people have obtained their first shot in the island nation, which has a population of 2.18 crores.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU